Sixera Pharma AB

 CEO: Maarten de Chateausixera_

Web: N/A

Description: Sixera Pharma is a biopharmaceutical company with expertise in dermatology, and especially rare genetic skin diseases (genodermatoses). We are focusing our drug development effort on protease biology in the skin and have developed a series of compounds targeting certain skin proteases (kallikreins) known to cause a rare inherited skin disease called Netherton’s syndrome. The lead compound is currently undergoing IND enabling studies.

Share Button